fbpx

December 2, 2016

Get Ready to Rumble! (with Jacob and Esau) 7 Haiku for Parsha Toldot

I
Enter Esau and
Jacob. Kicking each other’s
ass on the way out.

II
A miracle in
Philistine. Isaac grows more
crops than the locals.

III
Philistines protest
the wells Isaac digs. Here comes
real estate law.

IV
Abimelech comes
with peace. God comes to bless. A
good day for Isaac.

V
Poor blind Isaac. Can’t
tell his two sons apart. Tricked
by a hairy arm.

VI
Go and get a wife
Jacob, says mom. Escape from
the wrath of Esau.

VII
If brothers were judged
based on how many wives they
had. Esau would win.

Get Ready to Rumble! (with Jacob and Esau) 7 Haiku for Parsha Toldot Read More »

Rosner’s Torah Talk: Parashat Toldot with Rabbi Yael Saidoff

Our guest today is ” target=”_blank”>Parashat Toldot  (Genesis 25:19-28:9) – tells us the fascinating story of Jacob and Esau and of the selling of Esau's birth right to Jacob. Our talk focuses on the complex relationships between the four heroes of the parasha.

Our Past discussions of Toldot:

Rabbi Aderet Drucker on ” target=”_blank”>the demonizing of Essau in the Jewish tradition

Maharat Ruth Balinsky Friedman on Rosner’s Torah Talk: Parashat Toldot with Rabbi Yael Saidoff Read More »

Israel in Pictures – From Fire and Drought to a Raging Storm

Israel has been through a rough week, with wildfire raging inside forests and cities, leaving thousands without a home.  Some of the fires were caused by arsonists, some were caused due to negligence, but it was rough weather conditions and unbearable drought that made it so difficult for the firefighters to battle the flames, leaving such massive destruction.

Last night, finally, the rain came, in a much-anticipated storm, first one of the year.

Amateur photographer Edmont Pogoriler, followed the destruction path of the fire in Zikhron Ya'akov where he lives, and then beautifully captured the storm as it covered Israel's skies.

He gladly agreed to share his documentation with us.

Enjoy!

 

The fire in Zikhron Ya'akov – one of the most destructive fires to hit Israel last week

Israel in Pictures – From Fire and Drought to a Raging Storm Read More »

Weighing the Risks of Celebrex

Non-steroidal anti-inflammatory medicines (NSAIDs) have been around since the 1960s. They include ibuprofen (Advil, Motrin), naproxen (Aleve), meloxicam (Mobic), diclofenac (Voltaren) and over a dozen others. NSAIDs are used to treat pain, decrease fever, and decrease inflammation. They are prescribed over 100 million times annually in the US. Naproxen and ibuprofen are also available over the counter.

NSAIDs were a boon compared to the medications that were available before them. They are more effective for pain than acetaminophen (Tylenol), and are not addictive like opiates. But they do have some side effects. They decrease platelet function and thereby increase bleeding risk, and they can irritate the stomach lining and even cause ulcers. They can also cause kidney injury. These risks are quite small when used for the occasional headache or muscle sprain, but some patients require long-term daily pain medication. These patients’ risk of stomach bleeding from NSAIDs is substantial.

To address this risk, a novel family of medications emerged in the 1990s – COX-2 inhibitors. These medications were designed to have the analgesic and anti-inflammatory benefits of NSAIDs with much lower gastrointestinal risks. In the US two COX-2 inhibitors became available, celecoxib (Celebrex) in 1998 and rofecoxib (Vioxx) in 1999. But Vioxx was found to increase the risk of stroke and heart attack in patients taking it daily and was withdrawn from the market in 1999.

Thereafter it was discovered that traditional NSAIDs likely also increased stroke and heart attack risk somewhat, but the assumption was that Celebrex increased stroke and heart-attack risk more than NSAIDs because it was in the same family as Vioxx. After Vioxx’s withdrawal, the FDA allowed Celebrex to continue to be sold as long as its effect on stroke and heart attack risk was systematically evaluated. The resulting ” target=”_blank”>Study Suggests Celebrex Isn’t Riskier Than Rival Pain Drugs (Wall Street Journal)
” target=”_blank”>Celebrex May Not Pose More Heart Risk Than Others (WebMD)
Weighing the Risks of Celebrex Read More »